These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33856248)

  • 21. Increase in Diabetes Mortality Associated With COVID-19 Pandemic in the U.S.
    Ran J; Zhao S; Han L; Ge Y; Chong MKC; Cao W; Sun S
    Diabetes Care; 2021 Jul; 44(7):e146-e147. PubMed ID: 34135014
    [No Abstract]   [Full Text] [Related]  

  • 22. Diabetic emergencies presenting during the COVID-19 pandemic: A retrospective case analysis.
    Joseph T; Crawley E; Qamar S; Zosmer M; Rayanagoudar G; Nethaji C; Menon R
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00313. PubMed ID: 34716692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How diabetes management is adapting amid the COVID-19 pandemic.
    Ranscombe P
    Lancet Diabetes Endocrinol; 2020 Jul; 8(7):571. PubMed ID: 32422126
    [No Abstract]   [Full Text] [Related]  

  • 24. Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection.
    Burlando M; Russo R; Cozzani E; Parodi A
    Dermatol Ther; 2021 Jan; 34(1):e14641. PubMed ID: 33278049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text].
    Naderi-Azad S; Vender R
    J Cutan Med Surg; 2021; 25(2):169-176. PubMed ID: 33179534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S.
    Kim D; Alshuwaykh O; Sandhu KK; Dennis BB; Cholankeril G; Ahmed A
    Diabetes Care; 2022 Jun; 45(6):e107-e109. PubMed ID: 35446372
    [No Abstract]   [Full Text] [Related]  

  • 27. The far side of the pandemic: Has diabetic foot osteomyelitis been neglected due to COVID-19?
    Tsagkaris C; Laskaratou ED; Desse D; Kamaratos A
    Int J Health Plann Manage; 2022 Jan; 37(1):572-574. PubMed ID: 34664309
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic?
    Li H; Zhao Y; Zhou L
    Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adapting vascular care amidst a pandemic: Considering COVID-19 and looking forward.
    Bunte MC; Monteleone PP
    Vasc Med; 2021 Dec; 26(6):624-625. PubMed ID: 34380346
    [No Abstract]   [Full Text] [Related]  

  • 30. [Atypical presentation of diabetic foot in post-COVID-19 patients].
    Carro GV; Dini A; de Los Ríos Espada GB; Tamashiro G; Llanos MLÁ; Claros Fuentes DE
    Medicina (B Aires); 2021; 81(6):1076-1080. PubMed ID: 34875612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes Mellitus during the Pandemic Covid-19: Prevalence, Pathophysiology, Mechanism, and Management: An updated overview.
    Rais N; Ahmad R; Ved A; Parveen K; Ishrat T; Prakash O; Shadab M; Bari DG; Siddiqui NA
    Curr Diabetes Rev; 2022; 18(3):e120721194712. PubMed ID: 34931983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.
    Gisondi P; PIaserico S; Bordin C; Alaibac M; Girolomoni G; Naldi L
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2499-2504. PubMed ID: 32585074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underrecognized Peripheral Arterial Disease in Patients With Diabetes Mellitus in Thailand: We Must Consider Neuroischemic Foot Ulcers From This Fallout.
    Rerkasem K; Kosachunhanun N; Sony K; Inpankaew N; Mani R
    Int J Low Extrem Wounds; 2015 Jun; 14(2):132-5. PubMed ID: 26041734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enduring effect of the COVID-19 pandemic on diabetes.
    Al-Aly Z; Cao B
    Lancet Diabetes Endocrinol; 2024 Aug; 12(8):508-510. PubMed ID: 39054029
    [No Abstract]   [Full Text] [Related]  

  • 35. COVID-19 Pandemic and Virtual Clinics for Diabetes Care.
    Garg SK; Reinicke T
    Diabetes Technol Ther; 2021 Jun; 23(S2):S3-S15. PubMed ID: 34061640
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes Mellitus and COVID-19: Unholy Association of Two Pandemics.
    Kamrul-Hasan AB; Nessa A; Debnath CR
    Mymensingh Med J; 2021 Jan; 30(1):1-2. PubMed ID: 33397842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and Covid-19: Clinical implications and novel management strategies.
    D'Arcy R; Courtney CH
    Ulster Med J; 2021 May; 90(2):81-85. PubMed ID: 34276085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us.
    Stoian AP; Kempler P; Stulnig T; Rizvi AA; Rizzo M
    Metab Syndr Relat Disord; 2022 Apr; 20(3):137-140. PubMed ID: 34967689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes Epidemiology in the COVID-19 Pandemic.
    Selvin E; Juraschek SP
    Diabetes Care; 2020 Aug; 43(8):1690-1694. PubMed ID: 32540920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Service restriction during the COVID-19 pandemic and its impact on HbA
    Batten L; Chandrajay D; Burkinshaw C; Gill J; Jayagopal V
    Diabet Med; 2021 Jan; 38(1):e14414. PubMed ID: 33030220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.